Alpharx Inc (ALRX)

Alpharx Inc is related to 1 other symbol. To date we've encountered 7 releases involving Alpharx Inc.

Last Price: 0.05 (0.00) - 12/1/2008, 9:30am

• Open: N/A
• High: N/A
• Low: N/A

Alpharx Inc Options

• Alpharx Inc "Business Partners"
• Alpharx Inc Press Releases
• Alpharx Inc News
• Alpharx Inc Contact
• Alpharx Inc Related (via TRYNT)

Alpharx Inc "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Alpharx Inc.

• ENB

^

Alpharx Inc Press Releases

• AlphaRx Inc.: AlphaRx International Holdings Limited Enters Oncology Market (Trackbacks) (Backlinks), Wed, 18 Oct 2006 5:00:00 PDT

  HONG KONG (MARKET WIRE) AlphaRx International Holdings Limited ("AIH"), subsidiary of AlphaRx Inc. (OTCBB: ALRX), announces that they are entering into the multi billion dollars oncology market with two nanotechnology based products, to address hepatic and lung cancer respectively.

• AlphaRx Inc.: AlphaRx Files Second U.S. Patent Application for Its Nanoparticle Drug Delivery Platform (Trackbacks) (Backlinks), Thu, 12 Oct 2006 5:00:00 PDT

  MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX) announces that the Company has filed a second patent application with the U.S. Patent and Trademark Patent Office for its nanoparticle-based drug delivery platform covering several antibiotic products being developed by the Company targeted to treat life threatening infectious diseases.

• AlphaRx Inc.: AlphaRx Appoints Leading Ophthalmologist to Its Scientific Advisory Board (Trackbacks) (Backlinks), Mon, 25 Sep 2006 5:00:00 PDT

  MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX) is pleased to announce the appointment of Michael S. Berlin, M.D., M.S., dedicated to advancing and improving the care of patients with eye diseases, to its Scientific Advisory Board.

• AlphaRx Inc.: AlphaRx Receives Notice of Allowance From the US Patent Office (Trackbacks) (Backlinks), Tue, 12 Sep 2006 5:00:00 PDT

  MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled "Stabilization of Benzoyl Peroxide in Solution."

• Anti Aging Medical Group Corp. : Anti Aging Medical Group Acquires Distribution Rights for Vitamin Energy Supplement CoQ10 ER Extended Release (Trackbacks) (Backlinks), Tue, 6 Jun 2006 6:00:00 PDT

  TORONTO (MARKET WIRE) Anti Aging Medical Group Corp. (PINKSHEETS: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, announces the North American marketing rights for their brand new product, CoQ10 ER a dietary supplement created to protect against age-related degeneration. The

• AlphaRx Inc.: AlphaRx Enters a Collaboration to Develop Novel Compounds for Central Nervous System Disorders (Trackbacks) (Backlinks), Thu, 11 May 2006 5:00:00 PDT

  MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company, announced today that it has entered into a collaboration with PharmaSeed Ltd. of Israel, a bio-pharmaceutical company specializing in drug discovery and early development phases for the development of new drugs for the potential treatment of CNS disorders such as stroke and multiple sclerosis.

• AlphaRx Inc.: AlphaRx Enters Into Joint Venture Agreement With Leading Chinese Marketing Company to Distribute Its Proprietary Pharmaceutical and Consumer Product Lines Throughout Asia (Trackbacks) (Backlinks), Mon, 1 May 2006 5:00:00 PDT

  MARKHAM, ON (MARKET WIRE) AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, announced today that its wholly owned subsidiary, AlphaRx International Holdings Limited ("AIH"), has entered into a Joint Venture Agreement, ("JV") with a leading Chinese marketing company (the "China Party"), to establish a Joint Venture Company ("JV

^

Alpharx Inc News

• AlphaRx and Gaia BioPharma Enter Into Feasibility and Option Agreement (PR Newswire), Wed, 22 Oct 2008 12:00:00 Etc/GMT
• AlphaRx Appoints Leading Infectious Disease Specialist to Its Scientific Advisory Board (PR Newswire), Wed, 17 Sep 2008 12:00:00 Etc/GMT
• ALPHARX INC Financials (EDGAR Online Financials), Sat, 30 Aug 2008 13:04:21 Etc/GMT
• ALPHARX INC Files SEC form 10QSB, Quarterly Report (EDGAR Online), Thu, 14 Aug 2008 19:46:59 Etc/GMT
• ALPHARX INC Files SEC form 10QSB, Quarterly Report (EDGAR Online), Thu, 15 May 2008 10:09:14 Etc/GMT
• ALPHARX INC Files SEC form 10QSB, Quarterly Report (EDGAR Online), Tue, 12 Feb 2008 15:07:53 Etc/GMT
• AGORACOM Hosts 8 Emerging Companies in Small-Cap Pavilion At 22nd Annual Toronto Financial Forum (GlobeNewswire), Tue, 22 Jan 2008 18:07:39 Etc/GMT
• ALPHARX INC Files SEC form 10KSB, Annual Report (EDGAR Online), Thu, 20 Dec 2007 11:02:56 Etc/GMT
• ALPHARX INC Files SEC form 8-K, Unregistered Sale of Equity Securities (EDGAR Online), Thu, 29 Nov 2007 20:56:42 Etc/GMT

^

Alpharx Inc Contact

• For more information, please contact:
  Agora Investor Relations Corp.
  Web: http://www.agoracom.com
  E-mail: Email Contact
  
  

TRYNT Related

• Alpharx Inc (ALRX.OB)

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.